UnitedHealth Group’s Optum has won Federal Trade Commission approval of its $4 billion acquisition of DaVita Medical Group after a settlement was reached over allegations of a monopoly in the Las Vegas market.
UnitedHealth Group’s Optum has won Federal Trade Commission approval of its $4 billion acquisition of DaVita Medical Group after a settlement was reached over allegations of a monopoly in the Las Vegas market.